| EP2358746 - BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 23.07.2021 Database last updated on 01.04.2026 | |
| Former | The patent has been granted Status updated on 14.08.2020 | ||
| Former | Grant of patent is intended Status updated on 01.04.2020 | ||
| Former | Examination is in progress Status updated on 21.02.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Molecular Partners AG Wagistrasse 14 8952 Schlieren / CH | [2011/34] | Inventor(s) | 01 /
BINZ, Hans Kaspar Lüssirainstrasse 52 6300 Zug / CH | 02 /
FORRER, Patrik Unterfeld 6 6422 Steinen / CH | 03 /
STUMPP, Michael Tobias Chratzstrasse 6 8954 Geroldswil / CH | [2020/38] |
| Former [2011/34] | 01 /
BINZ, Hans Kaspar Bachstrasse 27 CH-8903 Birnensdorf / CH | ||
| 02 /
FORRER, Patrik Rainackerstrasse 17 CH-8953 Dietikon / CH | |||
| 03 /
STUMPP, Michael Tobias Chratzstrasse 6 CH-8954 Geroldswil / CH | Representative(s) | Latscha Schöllhorn Partner AG Grellingerstrasse 60 4052 Basel / CH | [2020/38] |
| Former [2014/43] | Latscha Schöllhorn Partner Latscha Schöllhorn Partner AG Austrasse 24 4051 Basel / CH | ||
| Former [2011/34] | Becker, Konrad Aeschenvorstadt 24 Postfach 318 4010 Basel / CH | Application number, filing date | 09756279.7 | 03.11.2009 | [2011/34] | WO2009EP64483 | Priority number, date | EP20080168166 | 03.11.2008 Original published format: EP 08168166 | [2011/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010060748 | Date: | 03.06.2010 | Language: | EN | [2010/22] | Type: | A1 Application with search report | No.: | EP2358746 | Date: | 24.08.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.06.2010 takes the place of the publication of the European patent application. | [2011/34] | Type: | B1 Patent specification | No.: | EP2358746 | Date: | 16.09.2020 | Language: | EN | [2020/38] | Search report(s) | International search report - published on: | EP | 03.06.2010 | Classification | IPC: | C07K14/47, A61K38/00, A61K47/60 | [2020/11] | CPC: |
C07K14/47 (EP,KR,RU,US);
A61K38/00 (EP,CN,RU,US);
C07K14/4703 (CN,RU,US);
A61K38/17 (KR,RU);
A61K47/60 (EP,RU,US);
A61P27/02 (EP);
A61P35/00 (EP);
A61P9/00 (EP);
A61P9/12 (EP);
|
| Former IPC [2011/34] | C07K14/47 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2020/38] |
| Former [2011/34] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | BINDUNGSPROTEINE ZUM HEMMEN DER VEGF-A-REZEPTORINTERAKTION | [2020/18] | English: | BINDING PROTEINS INHIBITING THE VEGF-A RECEPTOR INTERACTION | [2011/34] | French: | PROTÉINES DE LIAISON INHIBANT L'INTERACTION DU RÉCEPTEUR VEGF-A | [2020/18] |
| Former [2011/34] | DIE VEGF-A-REZEPTOR-WECHSELWIRKUNG INHIBIERENDE BINDUNGSPROTEINE | ||
| Former [2011/34] | PROTÉINES DE LIAISON INHIBANT L INTERACTION DU RÉCEPTEUR VEGF-A | Entry into regional phase | 20.05.2011 | National basic fee paid | 20.05.2011 | Designation fee(s) paid | 20.05.2011 | Examination fee paid | Examination procedure | 20.05.2011 | Examination requested [2011/34] | 22.12.2011 | Amendment by applicant (claims and/or description) | 15.01.2015 | Despatch of a communication from the examining division (Time limit: M06) | 20.07.2015 | Reply to a communication from the examining division | 09.10.2015 | Despatch of a communication from the examining division (Time limit: M06) | 18.04.2016 | Reply to a communication from the examining division | 17.10.2016 | Despatch of a communication from the examining division (Time limit: M06) | 10.04.2017 | Reply to a communication from the examining division | 17.08.2017 | Despatch of a communication from the examining division (Time limit: M06) | 22.02.2018 | Reply to a communication from the examining division | 31.05.2018 | Despatch of a communication from the examining division (Time limit: M06) | 07.12.2018 | Reply to a communication from the examining division | 11.04.2019 | Despatch of a communication from the examining division (Time limit: M06) | 18.10.2019 | Reply to a communication from the examining division | 02.04.2020 | Communication of intention to grant the patent | 06.08.2020 | Fee for grant paid | 06.08.2020 | Fee for publishing/printing paid | 06.08.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | EP20196328.7 / EP3785735 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.01.2015 | Opposition(s) | 17.06.2021 | No opposition filed within time limit [2021/34] | Fees paid | Renewal fee | 23.11.2011 | Renewal fee patent year 03 | 23.11.2012 | Renewal fee patent year 04 | 28.11.2013 | Renewal fee patent year 05 | 25.11.2014 | Renewal fee patent year 06 | 24.11.2015 | Renewal fee patent year 07 | 23.11.2016 | Renewal fee patent year 08 | 24.11.2017 | Renewal fee patent year 09 | 22.11.2018 | Renewal fee patent year 10 | 26.11.2019 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 03.11.2009 | AT | 16.09.2020 | CY | 16.09.2020 | CZ | 16.09.2020 | EE | 16.09.2020 | FI | 16.09.2020 | HR | 16.09.2020 | LT | 16.09.2020 | LV | 16.09.2020 | MC | 16.09.2020 | MK | 16.09.2020 | MT | 16.09.2020 | RO | 16.09.2020 | SI | 16.09.2020 | SK | 16.09.2020 | SM | 16.09.2020 | LU | 03.11.2020 | BG | 16.12.2020 | GR | 17.12.2020 | IS | 16.01.2021 | PT | 18.01.2021 | [2022/32] |
| Former [2022/27] | HU | 03.11.2009 | |
| AT | 16.09.2020 | ||
| CY | 16.09.2020 | ||
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| MC | 16.09.2020 | ||
| MT | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SI | 16.09.2020 | ||
| SK | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| LU | 03.11.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| IS | 16.01.2021 | ||
| PT | 18.01.2021 | ||
| Former [2021/36] | AT | 16.09.2020 | |
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| MC | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SI | 16.09.2020 | ||
| SK | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| LU | 03.11.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| IS | 16.01.2021 | ||
| PT | 18.01.2021 | ||
| Former [2021/33] | AT | 16.09.2020 | |
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| MC | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SK | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| LU | 03.11.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| IS | 16.01.2021 | ||
| PT | 18.01.2021 | ||
| Former [2021/31] | AT | 16.09.2020 | |
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| MC | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SK | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| IS | 16.01.2021 | ||
| PT | 18.01.2021 | ||
| Former [2021/28] | AT | 16.09.2020 | |
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SK | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| IS | 16.01.2021 | ||
| PT | 18.01.2021 | ||
| Former [2021/25] | AT | 16.09.2020 | |
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| IS | 16.01.2021 | ||
| PT | 18.01.2021 | ||
| Former [2021/24] | AT | 16.09.2020 | |
| CZ | 16.09.2020 | ||
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| PT | 18.01.2021 | ||
| Former [2021/23] | CZ | 16.09.2020 | |
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| SM | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| PT | 18.01.2021 | ||
| Former [2021/22] | CZ | 16.09.2020 | |
| EE | 16.09.2020 | ||
| FI | 16.09.2020 | ||
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| RO | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| PT | 18.01.2021 | ||
| Former [2021/21] | FI | 16.09.2020 | |
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| PT | 18.01.2021 | ||
| Former [2021/20] | FI | 16.09.2020 | |
| HR | 16.09.2020 | ||
| LT | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| Former [2021/10] | FI | 16.09.2020 | |
| HR | 16.09.2020 | ||
| LV | 16.09.2020 | ||
| BG | 16.12.2020 | ||
| GR | 17.12.2020 | ||
| Former [2021/08] | FI | 16.09.2020 | |
| BG | 16.12.2020 | Cited in | International search | [A] WO0220565 (UNIV ZUERICH et al.) [A] 1-20 * the whole document * | [A] WO2005056764 (COMPOUND THERAPEUTICS INC et al.) [A] 1-20 | [A] WO2008066752 (ADNEXUS A BRISTOL MEYERS SQUIB et al.) [A] 1-20 | [XY] INOKI ISAO ET AL: "Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.", THE FASEB JOURNAL : OFFICIAL PUBLICATION OF THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY FEB 2002 LNKD- PUBMED:11744618, vol. 16, no. 2, February 2002 (2002-02-01), pages 219 - 221, XP002577430, ISSN: 1530-6860 [X] 1 * the whole document *[Y] 2-20 | [Y] STUMPP M T ET AL: "DARPins: A new generation of protein therapeutics", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US LNKD- DOI:10.1016/J.DRUDIS.2008.04.013, vol. 13, no. 15-16, 1 August 2008 (2008-08-01), pages 695 - 701, XP023440383, ISSN: 1359-6446, [retrieved on 20080711] [Y] 2-20 * the whole document * DOI: http://dx.doi.org/10.1016/j.drudis.2008.04.013 | [A] FORRER P ET AL: "Consensus design of repeat proteins", CHEMBIOCHEM - A EUROPEAN JOURNAL OF CHEMICAL BIOLOGY, WILEY VCH, WEINHEIM, DE LNKD- DOI:10.1002/CBIC.200300762, vol. 5, no. 2, 6 February 2004 (2004-02-06), pages 183 - 189, XP002382372, ISSN: 1439-4227 [A] 1-20 DOI: http://dx.doi.org/10.1002/cbic.200300762 | [A] BINZ H K ET AL: "Designing Repeat Proteins: Well-expressed, Soluble and Stable Proteins from Combinatorial Libraries of Consensus Ankyrin Repeat Proteins", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 332, no. 2, 12 September 2003 (2003-09-12), pages 489 - 503, XP004450112, ISSN: 0022-2836 [A] 1-20 DOI: http://dx.doi.org/10.1016/S0022-2836(03)00896-9 | [A] BINZ H KASPAR ET AL: "High-affinity binders selected from designed ankyrin repeat protein libraries", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 22, no. 5, 1 May 2004 (2004-05-01), pages 575 - 582, XP002343919, ISSN: 1087-0156 [A] 1-20 DOI: http://dx.doi.org/10.1038/nbt962 |